Global Oncology Biosimilars Sales Market Report Forecast 2017-2021

May 2017 | 128 pages | ID: G583EF13FE3EN
S&P Consulting

Abstracts

The report offers a comprehensive evaluation of the market. It does so via in-depth insights, understanding market evolution by tracking historical developments, and analyzing the present scenario and future projections based on optimistic and likely scenarios. Each research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology developments, types, applications, and the competitive landscape.

The study is a source of reliable data on:

Key market segments and sub-segments
Evolving market trends and dynamics
Changing supply and demand scenarios
Quantifying market opportunities through market sizing and market forecasting
Tracking current trends/opportunities/challenges
Competitive insights
Opportunity mapping in terms of technological breakthroughs

This research report analyzes this market on the basis of its market segments, major geographies, and current market trends. Geographies analyzed under this research report include:

United States
China
Europe
Japan

The Major players reported in the market include:

Covidien llc (Medtronic)
Johnson & Johnson MEDICAL
Bolton Surgical
Platts & Nisbett
Frankenman International
Changzhou Waston
Jiangsu Qianjing Medical
Changzhou Anker Medical
Changzhou Tongchuang Medical

Product Segment Analysis:

Type 1
Type 2
Type 3

Application Segment Analysis:

Application 1
Application 2
Application 3

Reasons for Buying this Report

• This report provides pin-point analysis for changing competitive dynamics
• It provides a forward looking perspective on different factors driving or restraining market growth
• It provides a six-year forecast assessed on the basis of how the market is predicted to grow
• It helps in understanding the key product segments and their future
• It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
• It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
• It provides distinctive graphics and exemplified analysis of major market segments

Contents

Global Oncology Biosimilars Sales Market Report Forecast 2017-2021

1 ONCOLOGY BIOSIMILARS MARKET OVERVIEW

1.1 Product Overview and Scope of Oncology Biosimilars
1.2 Classification of Oncology Biosimilars
  1.2.1 Type
  1.2.2 Type
  1.2.3 Type
1.3 Application of Oncology Biosimilars
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 Oncology Biosimilars Market States Status and Prospect (2012-2021) by Regions
  1.4.1 United States
  1.4.2 China
  1.4.3 Europe
  1.4.4 Japan
1.5 Global Market Size of Oncology Biosimilars (2012-2021)
  1.5.1 Global Oncology Biosimilars Sales and Growth Rate (2012-2021)
  1.5.2 Global Oncology Biosimilars Revenue and Growth Rate (2012-2021)

2 GLOBAL ECONOMIC IMPACT ON ONCOLOGY BIOSIMILARS INDUSTRY

2.1 Global Macroeconomic Environment Analysis
  2.1.1 Global Macroeconomic Analysis
  2.1.2 Global Macroeconomic Environment Development Trend
2.2 Global Macroeconomic Environment Analysis by Regions

3 ONCOLOGY BIOSIMILARS MANUFACTURING COST ANALYSIS

3.1 Oncology Biosimilars Key Raw Materials Analysis
  3.1.1 Key Raw Materials
  3.1.2 Price Trend of Key Raw Materials
  3.1.3 Key Suppliers of Raw Materials
  3.1.4 Market Concentration Rate of Raw Materials
3.2 Proportion of Manufacturing Cost Structure
  3.2.1 Raw Materials
  3.2.2 Labor Cost
  3.2.3 Manufacturing Process Analysis of Oncology Biosimilars

4 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

4.1 Oncology Biosimilars Industrial Chain Analysis
4.2 Upstream Raw Materials Sourcing
4.3 Raw Materials Sources of Oncology Biosimilars Major Manufacturers in 2015
4.4 Downstream Buyers

5 GLOBAL ONCOLOGY BIOSIMILARS COMPETITION BY MANUFACTURERS, TYPE AND APPLICATION

5.1 Global Oncology Biosimilars Market Competition by Manufacturers
  5.1.1 Global Oncology Biosimilars Sales and Market Share of Key Manufacturers (2012-2017)
  5.1.2 Global Oncology Biosimilars Revenue and Share by Manufacturers (2012-2017)
5.2 Global Oncology Biosimilars (Volume and Value) by Type
  5.5.1 Global Oncology Biosimilars Sales and Market Share by Type (2012-2017)
  5.5.2 Global Oncology Biosimilars Revenue and Market Share by Type (2012-2017)
5.3 Global Oncology Biosimilars (Volume and Value) by Regions
  5.3.1 Global Oncology Biosimilars Sales and Market Share by Regions (2012-2017)
  5.3.2 Global Oncology Biosimilars Revenue and Market Share by Regions (2012-2017)
5.4 Global Oncology Biosimilars (Volume) by Application

6 UNITED STATES ONCOLOGY BIOSIMILARS (VOLUME, VALUE AND SALES PRICE)

6.1 United States Oncology Biosimilars Sales and Value (2012-2017)
  6.1.1 United States Oncology Biosimilars Sales and Growth Rate (2012-2017)
  6.1.2 United States Oncology Biosimilars Revenue and Growth Rate (2012-2017)
  6.1.3 United States Oncology Biosimilars Sales Price Trend (2012-2017)
6.2 United States Oncology Biosimilars Sales and Market Share by Manufacturers
6.3 United States Oncology Biosimilars Sales and Market Share by Type
6.4 United States Oncology Biosimilars Sales and Market Share by Application

7 CHINA ONCOLOGY BIOSIMILARS (VOLUME, VALUE AND SALES PRICE)

7.1 China Oncology Biosimilars Sales and Value (2012-2017)
  7.1.1 China Oncology Biosimilars Sales and Growth Rate (2012-2017)
  7.1.2 China Oncology Biosimilars Revenue and Growth Rate (2012-2017)
  7.1.3 China Oncology Biosimilars Sales Price Trend (2012-2017)
7.2 China Oncology Biosimilars Sales and Market Share by Manufacturers
7.3 China Oncology Biosimilars Sales and Market Share by Type
7.4 China Oncology Biosimilars Sales and Market Share by Application

8 EUROPE ONCOLOGY BIOSIMILARS (VOLUME, VALUE AND SALES PRICE)

8.1 Europe Oncology Biosimilars Sales and Value (2012-2017)
  8.1.1 Europe Oncology Biosimilars Sales and Growth Rate (2012-2017)
  8.1.2 Europe Oncology Biosimilars Revenue and Growth Rate (2012-2017)
  8.1.3 Europe Oncology Biosimilars Sales Price Trend (2012-2017)
8.2 Europe Oncology Biosimilars Sales and Market Share by Manufacturers
8.3 Europe Oncology Biosimilars Sales and Market Share by Type
8.4 Europe Oncology Biosimilars Sales and Market Share by Application

9 JAPAN ONCOLOGY BIOSIMILARS (VOLUME, VALUE AND SALES PRICE)

9.1 Japan Oncology Biosimilars Sales and Value (2012-2017)
  9.1.1 Japan Oncology Biosimilars Sales and Growth Rate (2012-2017)
  9.1.2 Japan Oncology Biosimilars Revenue and Growth Rate (2012-2017)
  9.1.3 Japan Oncology Biosimilars Sales Price Trend (2012-2017)
9.2 Japan Oncology Biosimilars Sales and Market Share by Manufacturers
9.3 Japan Oncology Biosimilars Sales and Market Share by Type
9.4 Japan Oncology Biosimilars Sales and Market Share by Application

10 GLOBAL ONCOLOGY BIOSIMILARS MANUFACTURERS ANALYSIS

10.1 Covidien llc (Medtronic)
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Product Type, Application and Specification
  10.1.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.1.4 Business Overview
10.2 Johnson & Johnson MEDICAL
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Product Type, Application and Specification
  10.2.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.2.4 Business Overview
10.3 Bolton Surgical
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Product Type, Application and Specification
  10.3.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.3.4 Business Overview
10.4 Platts & Nisbett
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Product Type, Application and Specification
  10.4.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.4.4 Business Overview
10.5 Frankenman International
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 Product Type, Application and Specification
  10.5.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.5.4 Business Overview
10.6 Changzhou Waston
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 Product Type, Application and Specification
  10.6.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.6.4 Business Overview
10.7 Jiangsu Qianjing Medical
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 Product Type, Application and Specification
  10.7.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.7.4 Business Overview
10.8 Changzhou Anker Medical
  10.8.1 Company Basic Information, Manufacturing Base and Competitors
  10.8.2 Product Type, Application and Specification
  10.8.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.8.4 Business Overview
10.9 Changzhou Tongchuang Medical
  10.9.1 Company Basic Information, Manufacturing Base and Competitors
  10.9.2 Product Type, Application and Specification
  10.9.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.9.4 Business Overview

11 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

11.1 Marketing Channel
  11.1.1 Direct Marketing
  11.1.2 Indirect Marketing
  11.1.3 Marketing Channel Development Trend
11.2 Market Positioning
  11.2.1 Pricing Strategy
  11.2.2 Brand Strategy
  11.2.3 Target Client
11.3 Distributors/Traders List

12 MARKET EFFECT FACTORS ANALYSIS

12.1 Technology Progress/Risk
  12.1.1 Substitutes Threat
  12.1.2 Technology Progress in Related Industry
12.2 Consumer Needs/Customer Preference Change
12.3 Economic/Political Environmental Change

13 GLOBAL ONCOLOGY BIOSIMILARS MARKET FORECAST (2017-2021)

13.1 Global Oncology Biosimilars Sales, Revenue Forecast (2017-2021)
13.2 Global Oncology Biosimilars Sales Forecast by Regions (2017-2021)
13.3 Global Oncology Biosimilars Sales Forecast by Type (2017-2021)
13.4 Global Oncology Biosimilars Sales Forecast by Application (2017-2021)

14 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Oncology Biosimilars
Table Classification of Oncology Biosimilars
Figure Global Sales Market Share of Oncology Biosimilars by Type in 2015
Table Applications of Oncology Biosimilars
Figure Global Sales Market Share of Oncology Biosimilars by Application in 2015
Figure United States Oncology Biosimilars Revenue and Growth Rate (2012-2021)
Figure China Oncology Biosimilars Revenue and Growth Rate (2012-2021)
Figure Europe Oncology Biosimilars Revenue and Growth Rate (2012-2021)
Figure Japan Oncology Biosimilars Revenue and Growth Rate (2012-2021)
Figure Global Oncology Biosimilars Sales and Growth Rate (2012-2021)
Figure Global Oncology Biosimilars Revenue and Growth Rate (2012-2021)
Table Global Oncology Biosimilars Sales of Key Manufacturers (2012-2017)
Table Global Oncology Biosimilars Sales Share by Manufacturers (2012-2017)
Figure 2015 Oncology Biosimilars Sales Share by Manufacturers
Figure 2016 Oncology Biosimilars Sales Share by Manufacturers
Table Global Oncology Biosimilars Revenue by Manufacturers (2012-2017)
Table Global Oncology Biosimilars Revenue Share by Manufacturers (2012-2017)
Table 2015 Global Oncology Biosimilars Revenue Share by Manufacturers
Table 2016 Global Oncology Biosimilars Revenue Share by Manufacturers
Table Global Oncology Biosimilars Sales and Market Share by Type (2012-2017)
Table Global Oncology Biosimilars Sales Share by Type (2012-2017)
Figure Sales Market Share of Oncology Biosimilars by Type (2012-2017)
Figure Global Oncology Biosimilars Sales Growth Rate by Type (2012-2017)
Table Global Oncology Biosimilars Revenue and Market Share by Type (2012-2017)
Table Global Oncology Biosimilars Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Oncology Biosimilars by Type (2012-2017)
Figure Global Oncology Biosimilars Revenue Growth Rate by Type (2012-2017)
Table Global Oncology Biosimilars Sales and Market Share by Regions (2012-2017)
Table Global Oncology Biosimilars Sales Share by Regions (2012-2017)
Figure Sales Market Share of Oncology Biosimilars by Regions (2012-2017)
Figure Global Oncology Biosimilars Sales Growth Rate by Regions (2012-2017)
Table Global Oncology Biosimilars Revenue and Market Share by Regions (2012-2017)
Table Global Oncology Biosimilars Revenue Share by Regions (2012-2017)
Figure Revenue Market Share of Oncology Biosimilars by Regions (2012-2017)
Figure Global Oncology Biosimilars Revenue Growth Rate by Regions (2012-2017)
Table Global Oncology Biosimilars Sales and Market Share by Application (2012-2017)
Table Global Oncology Biosimilars Sales Share by Application (2012-2017)
Figure Sales Market Share of Oncology Biosimilars by Application (2012-2017)
Figure Global Oncology Biosimilars Sales Growth Rate by Application (2012-2017)
Figure United States Oncology Biosimilars Sales and Growth Rate (2012-2017)
Figure United States Oncology Biosimilars Revenue and Growth Rate (2012-2017)
Figure United States Oncology Biosimilars Sales Price Trend (2012-2017)
Table United States Oncology Biosimilars Sales by Manufacturers (2012-2017)
Table United States Oncology Biosimilars Market Share by Manufacturers (2012-2017)
Table United States Oncology Biosimilars Sales by Type (2012-2017)
Table United States Oncology Biosimilars Market Share by Type (2012-2017)
Table United States Oncology Biosimilars Sales by Application (2012-2017)
Table United States Oncology Biosimilars Market Share by Application (2012-2017)
Figure China Oncology Biosimilars Sales and Growth Rate (2012-2017)
Figure China Oncology Biosimilars Revenue and Growth Rate (2012-2017)
Figure China Oncology Biosimilars Sales Price Trend (2012-2017)
Table China Oncology Biosimilars Sales by Manufacturers (2012-2017)
Table China Oncology Biosimilars Market Share by Manufacturers (2012-2017)
Table China Oncology Biosimilars Sales by Type (2012-2017)
Table China Oncology Biosimilars Market Share by Type (2012-2017)
Table China Oncology Biosimilars Sales by Application (2012-2017)
Table China Oncology Biosimilars Market Share by Application (2012-2017)
Figure Europe Oncology Biosimilars Sales and Growth Rate (2012-2017)
Figure Europe Oncology Biosimilars Revenue and Growth Rate (2012-2017)
Figure Europe Oncology Biosimilars Sales Price Trend (2012-2017)
Table Europe Oncology Biosimilars Sales by Manufacturers (2012-2017)
Table Europe Oncology Biosimilars Market Share by Manufacturers (2012-2017)
Table Europe Oncology Biosimilars Sales by Type (2012-2017)
Table Europe Oncology Biosimilars Market Share by Type (2012-2017)
Table Europe Oncology Biosimilars Sales by Application (2012-2017)
Table Europe Oncology Biosimilars Market Share by Application (2012-2017)
Figure Japan Oncology Biosimilars Sales and Growth Rate (2012-2017)
Figure Japan Oncology Biosimilars Revenue and Growth Rate (2012-2017)
Figure Japan Oncology Biosimilars Sales Price Trend (2012-2017)
Table Japan Oncology Biosimilars Sales by Manufacturers (2012-2017)
Table Japan Oncology Biosimilars Market Share by Manufacturers (2012-2017)
Table Japan Oncology Biosimilars Sales by Type (2012-2017)
Table Japan Oncology Biosimilars Market Share by Type (2012-2017)
Table Japan Oncology Biosimilars Sales by Application (2012-2017)
Table Japan Oncology Biosimilars Market Share by Application (2012-2017)
Table Covidien llc (Medtronic) Basic Information List
Table Covidien llc (Medtronic) Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Covidien llc (Medtronic) Oncology Biosimilars Global Market Share (2012-2017)
Table Johnson & Johnson MEDICAL Basic Information List
Table Johnson & Johnson MEDICAL Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Johnson & Johnson MEDICAL Oncology Biosimilars Global Market Share (2012-2017)
Table Bolton Surgical Basic Information List
Table Bolton Surgical Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Bolton Surgical Oncology Biosimilars Global Market Share (2012-2017)
Table Platts & Nisbett Basic Information List
Table Platts & Nisbett Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Platts & Nisbett Oncology Biosimilars Global Market Share (2012-2017)
Table Frankenman International Basic Information List
Table Frankenman International Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Frankenman International Oncology Biosimilars Global Market Share (2012-2017)
Table Changzhou Waston Basic Information List
Table Changzhou Waston Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Changzhou Waston Oncology Biosimilars Global Market Share (2012-2017)
Table Jiangsu Qianjing Medical Basic Information List
Table Jiangsu Qianjing Medical Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Jiangsu Qianjing Medical Oncology Biosimilars Global Market Share (2012-2017)
Table Changzhou Anker Medical Basic Information List
Table Changzhou Anker Medical Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Changzhou Anker Medical Oncology Biosimilars Global Market Share (2012-2017)
Table Changzhou Tongchuang Medical Basic Information List
Table Changzhou Tongchuang Medical Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Changzhou Tongchuang Medical Oncology Biosimilars Global Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Oncology Biosimilars
Figure Manufacturing Process Analysis of Oncology Biosimilars
Figure Oncology Biosimilars Industrial Chain Analysis
Table Raw Materials Sources of Oncology Biosimilars Major Manufacturers in 2015
Table Major Buyers of Oncology Biosimilars
Table Distributors/Traders List
Figure Global Oncology Biosimilars Sales and Growth Rate Forecast (2017-2021)
Figure Global Oncology Biosimilars Revenue and Growth Rate Forecast (2017-2021)
Table Global Oncology Biosimilars Sales Forecast by Regions (2017-2021)
Table Global Oncology Biosimilars Sales Forecast by Type (2017-2021)
Table Global Oncology Biosimilars Sales Forecast by Application (2017-2021)

COMPANIES MENTIONED

Covidien llc (Medtronic), Johnson & Johnson MEDICAL, Bolton Surgical, Platts & Nisbett, Frankenman International, Changzhou Waston, Jiangsu Qianjing Medical, Changzhou Anker Medical, Changzhou Tongchuang Medical, Jiangsu Reable Medical, Changzhou Resource Medical, Jiangsu Kangjin Medical, Pfizer, Wockhardt